OSE IMMUNOTHERAPEUTICS

Welcome to the Brand page for “OSE IMMUNOTHERAPEUTICS”, which is offered here for Pharmaceutical products in the nature of chemicals for cancer treatment, oncology and immunotherapy; sanitary preparations for medical purposes; pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; chemical preparations for medical or pharmaceutical purposes, for cancer treatment, oncology and immunotherapy for auto immune diseases and biological tissue grafts or skin grafts; pharmaceutical products, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; substances for medicinal use, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; vaccines for treating cancer; vaccines; substances for medicinal use, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; pharmaceutical products, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts;orphan synergy europe immune therapeutics;medical services;immunotherapeutics;scientific and technological services, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others;.

Its status is currently believed to be active. Its class is unavailable. “OSE IMMUNOTHERAPEUTICS” is believed to be currently owned by “OSE IMMUNOTHERAPEUTICS”.